Search company, investor...

Founded Year

2012

Stage

Bankrupt/Admin | Bankrupt

Total Raised

$5.1M

About 9 Meters Biopharma

9 Meters (Nasdaq: NMTR) is a gastrointestinal platform company focused on patients with rare disorders and unmet needs. The company's pipeline includes drug candidates for short bowel syndrome and celiac disease.

Headquarters Location

8480 Honeycutt Road Suite 120

Raleigh, North Carolina, 27615,

United States

919-275-1933

Loading...

Loading...

9 Meters Biopharma Patents

9 Meters Biopharma has filed 17 patents.

The 3 most popular patent topics include:

  • gastrointestinal tract disorders
  • digestive system
  • immune system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/25/2019

3/21/2023

Peptides, Amino acids, Proteins, Protein domains, Peptidase

Grant

Application Date

2/25/2019

Grant Date

3/21/2023

Title

Related Topics

Peptides, Amino acids, Proteins, Protein domains, Peptidase

Status

Grant

Latest 9 Meters Biopharma News

Delisting of Securities of Nymox Pharmaceutical Corporation; Aridis Pharmaceuticals Inc.; Novan, Inc.; ViewRay, Inc.; 9 Meters Biopharma, Inc.; Nabriva Therapeutics plc; UTA Acquisition Corporation; AppHarvest, Inc.; Yellow Corporation; Proterra Inc.; Amyris, Inc.; Chain Bridge I; LatAmGrowth SPAC; and SpringBig Holdings, Inc. from The Nasdaq Stock Market

Sep 7, 2023

New York, New York, UNITED STATES NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Nymox Pharmaceutical Corporation. Nymox Pharmaceutical Corporation’s securities were suspended on July 7, 2023, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock of Aridis Pharmaceuticals Inc. Aridis Pharmaceuticals Inc.’s securities were suspended on July 19, 2023, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock of Novan, Inc. Novan, Inc.’s securities were suspended on July 26, 2023, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock of ViewRay, Inc. ViewRay, Inc.’s securities were suspended on July 26, 2023, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock of 9 Meters Biopharma, Inc. 9 Meters Biopharma, Inc.’s securities were suspended on July 26, 2023, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the ordinary shares of Nabriva Therapeutics plc. Nabriva Therapeutics plc’s securities were suspended on August 1, 2023, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the warrants of UTA Acquisition Corporation. UTA Acquisition Corporation’s warrants were suspended on August 2, 2023, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock and warrants of AppHarvest, Inc. AppHarvest, Inc.’s warrants were suspended on August 2, 2023, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock of Yellow Corporation. Yellow Corporation’s securities were suspended on August 16, 2023, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock of Proterra Inc. Proterra Inc.’s securities were suspended on August 17, 2023, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock of Amyris, Inc. Amyris, Inc.’s securities were suspended on August 21, 2023, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the warrants of Chain Bridge I. Chain Bridge I’s warrants were suspended on August 23, 2023, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the warrants of LatAmGrowth SPAC. LatAmGrowth SPAC’s warrants were suspended on August 25, 2023, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock and warrants of SpringBig Holdings, Inc. SpringBig Holdings, Inc.’s securities were suspended on September 5, 2023, and have not traded on Nasdaq since that time. For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series .

9 Meters Biopharma Frequently Asked Questions (FAQ)

  • When was 9 Meters Biopharma founded?

    9 Meters Biopharma was founded in 2012.

  • Where is 9 Meters Biopharma's headquarters?

    9 Meters Biopharma's headquarters is located at 8480 Honeycutt Road, Raleigh.

  • What is 9 Meters Biopharma's latest funding round?

    9 Meters Biopharma's latest funding round is Bankrupt/Admin.

  • How much did 9 Meters Biopharma raise?

    9 Meters Biopharma raised a total of $5.1M.

  • Who are the investors of 9 Meters Biopharma?

    Investors of 9 Meters Biopharma include SDS Capital Partners and Monster Digital.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.